HELMINTOX

This brand name is authorized in France, Lithuania, Tunisia.

Active ingredients

The drug HELMINTOX contains one active pharmaceutical ingredient (API):

1
UNII 81BK194Z5M - PYRANTEL PAMOATE
 

Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis of the nematodes and thereby allow removal from the gastro intestinal (GI) system by peristalsis.
 
Read more about Pyrantel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P02CC01 Pyrantel P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CC Tetrahydropyrimidine derivatives
Discover more medicines within P02CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 64047571, 67669621
LT Valstybinė vaistų kontrolės tarnyba 1013932, 1013934, 1013939
TN Direction de la Pharmacie et du Médicament 5693031, 5693033

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈